Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Preconceptions versus experience of transvaginal ultrasonography in older women.

Kew FM, Whittaker VJ, Cruickshank DJ.

Ultrasound Obstet Gynecol. 2004 Oct;24(5):572-4.

2.

Tolerability of transvaginal ultrasonography as an ovarian cancer screening test.

Kew FM, Ashton VJ, Cruickshank DJ.

J Med Screen. 2004;11(1):45-7.

PMID:
15006114
3.

Psychological impact of screening for familial ovarian cancer.

Wardle FJ, Collins W, Pernet AL, Whitehead MI, Bourne TH, Campbell S.

J Natl Cancer Inst. 1993 Apr 21;85(8):653-7.

PMID:
8468723
4.

Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.

Hensley ML, Robson ME, Kauff ND, Korytowsky B, Castiel M, Ostroff J, Hurley K, Hann LE, Colon J, Spriggs D.

Gynecol Oncol. 2003 Jun;89(3):440-6.

PMID:
12798709
5.

Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.

Gentry-Maharaj A, Sharma A, Burnell M, Ryan A, Amso NN, Seif MW, Turner G, Brunell C, Fletcher G, Rangar R, Fallowfield L, Campbell S, Jacobs I, Menon U.

Ultrasound Obstet Gynecol. 2013 Jan;41(1):73-9. doi: 10.1002/uog.12262. Epub 2012 Dec 11.

6.

[Mass-screening for ovarian cancer by means of transvaginal ultrasonography].

Sato S, Hasuo Y, Ohta S, Maruyama H, Kagiya A, Saito Y.

Nihon Sanka Fujinka Gakkai Zasshi. 1992 Jun;44(6):683-8. Japanese.

PMID:
1506730
7.

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

Bourne TH, Campbell S, Reynolds KM, Whitehead MI, Hampson J, Royston P, Crayford TJ, Collins WP.

BMJ. 1993 Apr 17;306(6884):1025-9.

8.

Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter.

Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ, van Nagell JR Jr.

Obstet Gynecol. 2003 Sep;102(3):594-9.

PMID:
12962948
9.

Screening transvaginal ultrasonography of postmenopausal women in a private office setting.

Holbert TR.

Am J Obstet Gynecol. 1994 Jun;170(6):1699-703; discussion 1703-4.

PMID:
8203429
10.

Ovarian cancer screening in women with a family history of breast or ovarian cancer.

Lacey JV Jr, Greene MH, Buys SS, Reding D, Riley TL, Berg CD, Fagerstrom RM, Hartge P.

Obstet Gynecol. 2006 Nov;108(5):1176-84.

PMID:
17077240
11.

Ovarian cancer screening in the general population.

Menon U, Jacobs IJ.

Curr Opin Obstet Gynecol. 2001 Feb;13(1):61-4. Review.

PMID:
11176234
12.

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

van Nagell JR Jr, DePriest PD, Reedy MB, Gallion HH, Ueland FR, Pavlik EJ, Kryscio RJ.

Gynecol Oncol. 2000 Jun;77(3):350-6.

PMID:
10831341
13.
14.

Ovarian cancer screening.

Alexander-Sefre F, Menon U, Jacobs IJ.

Hosp Med. 2002 Apr;63(4):210-3. Review.

PMID:
11995270
15.

Women at risk of ovarian cancer: attitudes towards and expectations of the familial ovarian cancer clinic.

Sheppard R, Fry A, Rush R, Steel CM, Cull A.

Fam Cancer. 2001;1(1):31-7.

PMID:
14574013
16.

Postmenopausal women undergoing transvaginal ultrasound screening prefer not to have chaperones.

Sharma A, Beveridge HA, Fallowfield LJ, Jacobs IJ, Menon U.

BJOG. 2006 Aug;113(8):954-7. Epub 2006 Jul 7.

17.

Transvaginal Sonography: perception and attitude of Nigerian women.

Okeji MC, Agwuna KK, Ihudiebube-Splendor CN, Izge IY, Ekuma KK, Emeter JO.

BMC Womens Health. 2017 Jul 27;17(1):54. doi: 10.1186/s12905-017-0413-z.

18.

Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program.

Lykins EL, Pavlik EL, Andrykowski MA.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):490-3.

19.

Screening for ovarian cancer in the general population.

Chu CS, Rubin SC.

Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):307-20. Epub 2005 Dec 20. Review.

PMID:
16364690
20.

Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.

Kurjak A, Prka M, Arenas JM, Sparac V, Merce LT, Corusic A, Ivancic-Kosuta M.

Croat Med J. 2005 Oct;46(5):757-64.

Supplemental Content

Support Center